Navigation Links
ADSC's Pain Management Reinforcement
Date:10/13/2009

ment practice.

About Advanced Data Systems (ADS): ADS is a leading provider of healthcare automation solutions to medical practices of every size and specialty. The company produces its own systems, which include the MedicsDocAssistant CCHIT Certified® EHR, MedicsPremier for Practice Management and MedicsRIS for Radiology. ADS performs quick Implementation, comprehensive Training and excellent ongoing software Support which always includes updates. Our systems can be configured as Client Server or ASP, and are available separately per the needs of the practice. Over 35,000 physicians rely on solutions from ADS.

About Pain Centers of America, PA: PCA is a high volume Pain Management practice serving northern NJ. Virtually every type of Pain Management procedure is performed by physicians at PCA for both ambulatory patients and inpatients. Contact PCA at 973-779-7246 for more information on the practice and procedures performed.

###

Read the full story at http://www.prweb.com/releases/2009/10/prweb3028904.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015
2. Versus Technology Provides Real-Time Patient Flow and Volume Management to Eastern Maine Medical Centers New Imaging Center
3. Telesoft Announces Advanced Dispute Management Capabilities with Version 9.5
4. Southeast Alabama Medical Center Deploys Ekahaus Wireless Temperature Management Solution
5. QHR Ranked 7th Largest Healthcare Management Consulting Firm in United States
6. CCMC Celebrates Case Management Week (Oct. 11-17) With Second Annual Patricia McCollom Scholarship
7. High Cost of Chronic Illness Spotlights Need for Case Management Professionals
8. CDPHP Honored for Best Disease Management Program in Upstate New York
9. Hard to Treat Diseases (HTDS) Management Discussion
10. New Presentation Highlights Importance of In-Hospital Hyperglycemia Management and Appropriate Discharge Planning for Diabetes Patients
11. Physician Reimbursement and Their Practice Survival Defended by American National Medical Management

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2009)...’s attorneys are offering a free XOLAIR case... experienced heart attack, stroke or other serious... St. Louis, MO (Vocus) November 22, ...fering free XOLAIR case review for serious health...torneys of the Onder Law Firm include experienced ...
(Date:11/22/2009)... surgeon, Dr. Gulani continues to innovate and rai...on beyond 20/20.,Known as the Doctor’s Docto...published in teaching LASIK surgeons globally , ...vember 22, 2009 -- Dr. Arun C. Gulani of Gulani V...earch as one of the leading Laser Eye Surgeons of ...
(Date:11/22/2009)...en people have malaria, they are infected with Pla...aliva of a mosquito, infect cells in the liver, an... cells, the parasites replicate and also begin to ...change the physical nature of the cells in the blo...lood cells are stiffer and stickier than normal on...
(Date:11/22/2009)...nt, diverse and constant, but inflammation is unde..., San Diego School of Medicine now shows that the ... a pathway that prevents excessive inflammation af... us," said Richard L. Gallo, MD, PhD, professor of... of Dermatology and the Dermatology section of the...
(Date:11/22/2009)...tists from Weill Cornell Medical College have disc...a powerful target for the treatment of non-Hodgkin...ytes, or white blood cells. By exploiting this mec...uppress tumor formation in lab testing and in anim...esign of a clinical trial that will soon be under ...
Breaking Medicine News(10 mins):Health News:The Attorneys of The Onder Law Firm Offers Free XOLAIR Case Review 2Health News:Dr. Arun Gulani Listed in Forbes Magazine as One of The Leading Laser Eye Surgeons of the United States 2Health News:Measuring and modeling blood flow in malaria 2Health News:Surface bacteria maintain skin's healthy balance 2Health News:New cancer target for non-Hodgkin's lymphoma 2
...2 Perot Systems,Corporation (NYSE: PER ) and Sur...eement in which Perot Systems will implement advan...r business growth. Through this,agreement, Perot S...ountry. Perot Systems, services will include:,stra...
...a Motor Co., Ltd. will showcase an,experimental mo... walking,for the elderly and other people with wea... on Barrier Free Equipments & Rehabilitation for,t...w.newscom.com/cgi-bin/prnh/20080422/LATU095A ), D...
... 2008 Help is on the way for patients who have un...om chronic pain in their backs and legs, thanks to...pain management specialists. , Called a hybrid ...pheral nerve field stimulation (PNFS). This lates...
...ity, may abolish post-operative arthritic knee pai...ective surgery to repair a common sports-related k...nt), is now available in Michigan., "This innovat...o a degree never seen before with traditional ACL,...
...ints to a new strategy for preventing or possibly ...organ and tissue damage researchers at the Unive...have determined that a molecule called Epac (Excha...ine edition of the Proceedings of the National Aca...
...OrbusNeich,s Genous Bio-engineered,R stent will be...sty Summit,TCT 2008 Asia Pacific., The symposium,...on,Center of Sheraton Grande Walkerhill Seoul Hote...al Progenitor Cell Capture Technology and Beyond" ...
Other Medicine News:Health News:Perot Systems and Surgical Care Affiliates Sign Five-Year Agreement to Implement Advanced Technology Solutions 2Health News:Perot Systems and Surgical Care Affiliates Sign Five-Year Agreement to Implement Advanced Technology Solutions 3Health News:Honda to Showcase Experimental Walking Assist Device 2Health News:Mix of 2 pain-relief procedures can end chronic back and leg pain without drugs 2Health News:Mix of 2 pain-relief procedures can end chronic back and leg pain without drugs 3Health News:Two Michigan Orthopedic Surgeons Pioneer Innovative ACL Surgery with New Benefits for Athletes, Weekend Warriors 2Health News:Two Michigan Orthopedic Surgeons Pioneer Innovative ACL Surgery with New Benefits for Athletes, Weekend Warriors 3Health News:Scientists identify novel way to prevent cardiac fibrosis 2Health News:Symposium at Angioplasty Summit TCT Asia Pacific 2008 Features OrbusNeich's Genous(TM) Bio-engineered R stent(TM) 2
(Date:11/21/2009)...ASHINGTON, Nov. 21 An urgent need ...seases in the developing world has prompted a grow...chers, non-profit product development partnerships...anies. As noted today in a symposium at the 58th a...Medicine and Hygiene (ASTMH), these collaborations...
(Date:11/20/2009)...WAYNE, Pa., Nov. 20 Esca...the results for its fiscal first quarter ended Sep...fiscal 2010, product revenue decreased approximate...ee-month period ended September 30, 2009 as compar...ny reported the decreased net revenue of $8,434,00...
(Date:11/20/2009)..., BOSTON, Nov. 20 The United Stat...an earlier District Court ruling yesterday, approv...sale Price (AWP) pharmaceutical litigation against... http://www.newscom.com/cgi-bin/prnh/20080317/AQM1...t awarded consumers who purchased the pharmaceutic...
Breaking Medicine Technology:ASTMH Symposium Showcases Efforts To Meet the Need for New Medicines to Treat Infectious Diseases in Developing Countries 2ASTMH Symposium Showcases Efforts To Meet the Need for New Medicines to Treat Infectious Diseases in Developing Countries 3Escalon(R) Reports First Quarter Fiscal 2010 Results 2Escalon(R) Reports First Quarter Fiscal 2010 Results 3Escalon(R) Reports First Quarter Fiscal 2010 Results 4Escalon(R) Reports First Quarter Fiscal 2010 Results 5Escalon(R) Reports First Quarter Fiscal 2010 Results 6Escalon(R) Reports First Quarter Fiscal 2010 Results 7U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 3Second U S Egypt Collaborative Clinical Study Blocked by New York State Department of Health 28NYSDOH 29 This Time on Complications of Diabetes 14045 1Second U S Egypt Collaborative Clinical Study Blocked by New York State Department of Health 28NYSDOH 29 This Time on Complications of Diabetes 14045 2Second U S Egypt Collaborative Clinical Study Blocked by New York State Department of Health 28NYSDOH 29 This Time on Complications of Diabetes 14045 3Texas Cardiac Arrhythmia Institute at St Davids Medical Center Orders 4 Odyssey Systems 57150 1Texas Cardiac Arrhythmia Institute at St Davids Medical Center Orders 4 Odyssey Systems 57150 2Texas Cardiac Arrhythmia Institute at St Davids Medical Center Orders 4 Odyssey Systems 57150 3Texas Cardiac Arrhythmia Institute at St Davids Medical Center Orders 4 Odyssey Systems 57150 4GENova gains access to Big Pharma 57148 1GENova gains access to Big Pharma 57148 2GENova gains access to Big Pharma 57148 3
...itor, and R7128, nucleoside polymerase inhibitor, ...n patients with hepatitis C - , , NUTLEY, N.J., ...oche, InterMune, Inc. (Nasdaq: ITMN ) and Pharma...esults from their innovative, interferon-free regi...herapy for the treatment of patients chronically i...
...rmed to date will be presented during the Internat...nnual Meeting in Paris, France on April 24, 2009 ...d as an in vitro assessment of cell-mediated imm...erous clinical investigations have contributed to ...g recipients of solid organ transplants. , , (Lo...
Other Medicine Technology:Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 2Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 3Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 4Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 5Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 6Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 7Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 8Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 9Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 10Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 11An Independent Study Reports on the Utility of ImmuKnow(R), the Cylex(TM) Immune Cell Function Assay, for Monitoring Heart Transplant Recipients 2
...cientific principles supporting the effectiveness ...sed upon extensive clinical studies. As a woman ne...vel increases, thereby, elevating the salt in her ...ed to dry, crystalization occurs. The closer a wom...
Gastroccult Gastric Occult and pH Test
SureStep™ FSH Menopause Test (mid-stream)
FSH Home Menopause Test Midstream (Urine)
Medicine Products: